Company Overview of Samsung Biologics Co., Ltd.
Samsung Biologics Co., Ltd. develops and manufactures biological products through genetic engineering, cell culture technology, purification, and fill and finish technology. It focuses on offering biologics development and manufacturing solutions for the manufacture of therapeutic proteins. The company provides process development services, including cell line development programs, and upstream and downstream process development services. It also provides contract management services that comprise cGMP manufacturing programs for cell line development, process and analytical development, clinical phase I/II/III manufacturing, full-scale commercial manufacturing, and aseptic fill and finish op...
Founded in 2011
Key Executives for Samsung Biologics Co., Ltd.
Chief Executive Officer, President and Director
Vice President of Corporate Business Operation
Chief Information Officer and Vice President
Executive Vice President and Director
Compensation as of Fiscal Year 2014.
Samsung Biologics Co., Ltd. Key Developments
Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM
Jun 17 14
Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM. Venue: San Diego Convention Center, San Diego, California, United States.
Samsung Biologics Announces the Expansion of Existing Manufacturing Agreement with Bristol-Myers Squibb
Apr 23 14
Samsung BioLogics has announced that it has expanded its existing manufacturing agreement with Bristol-Myers Squibb. BMS's president of Global Manufacturing & Supply noted that the expanded agreement, will give the company flexibility to respond to increased demand in order to meet the global needs of patients. Details of which products will be covered by the deal or financial considerations have not yet been disclosed.
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement
Apr 22 14
Bristol-Myers Squibb Company and Samsung BioLogics announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site. Financial terms of the agreement are not disclosed. Bristol-Myers Squibb and Samsung announced their first manufacturing agreement in July 2013 to collaborate in the production of a single commercial antibody cancer drug substance.
Similar Private Companies By Industry
Recent Private Companies Transactions
Most Searched Private Companies
Sponsored Financial Commentaries